Literature DB >> 3530029

Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans.

T Mandrup-Poulsen, K Bendtzen, J Nerup, J Egeberg, J H Nielsen.   

Abstract

Supernatants of peripheral blood mononuclear cells from healthy human donors stimulated with recall antigen (purified protein derivative of tuberculin) or lectin (phytohaemagglutinin) markedly inhibited the insulin release from isolated human and rat islets of Langerhans, and decreased rat islet contents of insulin and glucagon in a dose-dependent manner. A maximal effect on islet function was obtained with supernatant concentrations down to 5%. Supernatants of mononuclear cells stimulated with tuberculin were more potent than supernatants produced by lectin stimulation. Culture medium reconstituted with tuberculin or phytohaemagglutinin did not impair islet function. Electron microscopy demonstrated that supernatants were cytotoxic to islet cells. The cytotoxic mononuclear cell mediator(s) was non-dialysable, sensitive to heating to 56 degrees C, labile even when stored at -70 degrees C, but stable when lyophilised.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530029     DOI: 10.1111/j.1398-9995.1986.tb02025.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  17 in total

1.  Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation.

Authors:  J H Hughes; J R Colca; R A Easom; J Turk; M L McDaniel
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

2.  Viral infection induces cytokine release by beta islet cells.

Authors:  M G Cavallo; M G Baroni; A Toto; A J Gearing; T Forsey; D Andreani; R Thorpe; P Pozzilli
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

Review 3.  Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.

Authors:  David L Morris
Journal:  Mol Endocrinol       Date:  2015-05-22

Review 4.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

5.  Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J Nerup; C A Dinarello; M Svenson; J H Nielsen
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

6.  Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans.

Authors:  G A Spinas; B S Hansen; S Linde; W Kastern; J Mølvig; T Mandrup-Poulsen; C A Dinarello; J H Nielsen; J Nerup
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

7.  Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

Authors:  M G Cavallo; P Pozzilli; C Bird; M Wadhwa; A Meager; N Visalli; A J Gearing; D Andreani; R Thorpe
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

8.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.

Authors:  J A Corbett; J L Wang; M A Sweetland; J R Lancaster; M L McDaniel
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.

Authors:  Y Kato; Y Miura; N Yamamoto; N Ozaki; Y Oiso
Journal:  Diabetologia       Date:  2003-07-24       Impact factor: 10.122

Review 10.  On the pathogenesis of IDDM.

Authors:  J Nerup; T Mandrup-Poulsen; S Helqvist; H U Andersen; F Pociot; J I Reimers; B G Cuartero; A E Karlsen; U Bjerre; T Lorenzen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.